Search

Your search keyword '"Deiman, B."' showing total 45 results

Search Constraints

Start Over You searched for: Author "Deiman, B." Remove constraint Author: "Deiman, B."
45 results on '"Deiman, B."'

Search Results

1. External validation of the PAGE-B score for HCC risk prediction in people living with HIV/HBV coinfection

2. HCV micro-elimination in individuals with HIV in the Netherlands 4 years after universal access to direct-acting antivirals: a retrospective cohort study

3. Real-world effectiveness and tolerability of switching to doravirine-based antiretroviral therapy in people with HIV: a nationwide, matched, prospective cohort study

4. Trends in mortality in people with HIV from 1999 to 2020: a multi-cohort collaboration

5. External Quality Assessment on Molecular Tumor Profiling with Circulating Tumor DNA-Based Methodologies Routinely Used in Clinical Pathology within the COIN Consortium

6. Risk for non-AIDS-defining and AIDS-defining cancer of early versus delayed initiation of antiretroviral therapy

7. Risk for non-AIDS-defining and AIDS-defining cancer of early versus delayed initiation of antiretroviral therapy: A multinational prospective cohort study

8. Management of drug interactions with direct‐acting antivirals in Dutch HIV/hepatitis C virus‐coinfected patients: adequate but not perfect

10. Human immunodeficiency virus continuum of care in 11 european union countries at the end of 2016 overall and by key population: Have we made progress?

11. A highly virulent variant of HIV-1 circulating in the Netherlands

12. Human Immunodeficiency Virus Continuum of Care in 11 European Union Countries at the End of 2016 Overall and by Key Population: Have We Made Progress?

13. Gender differences in the use of cardiovascular interventions in HIV‐positive persons; the D:A:D Study

14. HCV micro-elimination in individuals with HIV in the Netherlands 4 years after universal access to direct-acting antivirals: a retrospective cohort study

16. Abstracts of presentations on plant protection issues at the xth international congress of virology: August 11–16,1996 Binyanei haOoma, Jerusalem, Israel Part 2 Plenary Lectures

17. Progression of liver fibrosis following acute hepatitis C virus infection in HIV-positive MSM

18. Predictive Performance of Cardiovascular Disease Risk Prediction Algorithms in People Living With HIV

21. High treatment uptake in human immunodeficiency virus/ hepatitis C virus-coinfected patients after unrestricted access to direct-acting antivirals in the Netherlands

22. Abstracts of presentations on plant protection issues at the xth international congress of virology: August 11-16,1996 Binyanei haOoma, Jerusalem, Israel Part 2 Plenary Lectures

23. Cumulative and current exposure to potentially nephrotoxic antiretrovirals and development of chronic kidney disease in HIV-positive individuals with a normal baseline estimated glomerular filtration rate: a prospective international cohort study

24. Development and validation of a risk score for chronic kidney disease in HIV infection using prospective cohort data from the D:A:D study

25. Development and Validation of a Risk Score for Chronic Kidney Disease in HIV Infection Using Prospective Cohort Data from the D:A:D Study

31. Abstracts of presentations on plant protection issues at the xth international congress of virology: August 11-16,1996 Binyanei haOoma, Jerusalem, Israel Part 2 Plenary Lectures

32. External Quality Assessment on Molecular Tumor Profiling with Circulating Tumor DNA-Based Methodologies Routinely Used in Clinical Pathology within the COIN Consortium.

33. Up-front mutation detection in circulating tumor DNA by droplet digital PCR has added diagnostic value in lung cancer.

34. Dutch National Round Robin Trial on Plasma-Derived Circulating Cell-Free DNA Extraction Methods Routinely Used in Clinical Pathology for Molecular Tumor Profiling.

35. Cerebrospinal Fluid Analysis Post-COVID-19 Is Not Suggestive of Persistent Central Nervous System Infection.

36. Sensitive detection and quantification of SARS-CoV-2 by multiplex droplet digital RT-PCR.

37. Therapy Monitoring of EGFR-Positive Non-Small-Cell Lung Cancer Patients Using ddPCR Multiplex Assays.

38. Circulating biomarkers for monitoring therapy response and detection of disease progression in lung cancer patients.

39. Sensitive cell-free tumor DNA analysis in supernatant pleural effusions supports therapy selection and disease monitoring of lung cancer patients.

40. Optimized (Pre) Analytical Conditions and Workflow for Droplet Digital PCR Analysis of Cell-Free DNA from Patients with Suspected Lung Carcinoma.

41. Efficient amplification with NASBA of hepatitis B virus, herpes simplex virus and methicillin resistant Staphylococcus aureus DNA.

42. Strand specific quantitative real-time PCR to study replication of hepatitis C virus genome.

43. Characteristics and applications of nucleic acid sequence-based amplification (NASBA).

44. In vitro transcription by the turnip yellow mosaic virus RNA polymerase: a comparison with the alfalfa mosaic virus and brome mosaic virus replicases.

45. Efficient transcription of the tRNA-like structure of turnip yellow mosaic virus by a template-dependent and specific viral RNA polymerase obtained by a new procedure [corrected].

Catalog

Books, media, physical & digital resources